INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 2,257,912 Value ($000) $297,864 Avg Close — Range —
Q4 2024
Shares 139,660 Value ($000) $11,664 Avg Close — Range —
Q2 2024
Shares 406,714 Value ($000) $27,856 Avg Close — Range —
Q1 2024
Shares 410,634 Value ($000) $28,416 Avg Close — Range —
Q4 2023
Shares 309,993 Value ($000) $22,202 Avg Close — Range —
Q2 2023
Shares 130,607 Value ($000) $8,270 Avg Close — Range —
Q1 2023
Shares 7,325 Value ($000) $397 Avg Close — Range —
Q4 2022
Shares 668 Value ($000) $35 Avg Close — Range —
Q3 2022
Shares 5,308 Value ($000) $247 Avg Close — Range —
Q1 2022
Shares 31,967 Value ($000) $1,956 Avg Close — Range —
Q3 2018
Shares 508,750 Value ($000) $11,040 Avg Close — Range —
Q2 2018
Shares 457,891 Value ($000) $8,091 Avg Close — Range —
Q1 2018
Shares 402,126 Value ($000) $8,465 Avg Close — Range —
Q4 2017
Shares 110,153 Value ($000) $1,595 Avg Close — Range —
Q3 2017
Shares 139,353 Value ($000) $2,199 Avg Close — Range —
Q1 2016
Shares 55,100 Value ($000) $1,532 Avg Close — Range —
Q4 2015
Shares 9,370 Value ($000) $504 Avg Close — Range —
Q2 2015
Shares 50,000 Value ($000) $1,598 Avg Close — Range —